Filing Details

Accession Number:
0001415889-24-010452
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-05 18:15:49
Reporting Period:
2024-04-03
Accepted Time:
2024-04-05 18:15:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705850 E Joseph Gilliam C/O Glaukos Corporation
One Glaukos Way
Aliso Viejo CA 92656
President & Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-03 200 $55.18 102,045 No 4 M Direct
Common Stock Disposition 2024-04-03 200 $96.61 101,845 No 4 S Direct
Common Stock Acquisiton 2024-04-04 200 $55.18 102,045 No 4 M Direct
Common Stock Disposition 2024-04-04 200 $96.57 101,845 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-03 200 $0.00 200 $55.18
Common Stock Stock Option (Right to Buy) Disposition 2024-04-04 200 $0.00 200 $55.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
43,396 2032-03-24 No 4 M Direct
43,196 2032-03-24 No 4 M Direct
Footnotes
  1. Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
  3. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
  4. The option was granted by the Issuer on March 24, 2022 and vests upon the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.